CVs THD

PhD in Physico-Chemistry Applied to Biology (1986) Director of Preclinical Development

After managing the Laboratory of Analytical Chemistry at Helena Rubinstein (L’Oréal Group), Marc was involved in creating Bioxytech in 1989, a French biotech company focused on Free Radical Biology. Marc led R&D projects and pre-clinical studies for 10 years within Bioxytech/Oxis SA and acted as Director of Biology of Oxis SA. Marc joined Expertise and Consulting, a CRO in Medicinal Chemistry, before co-founding Tetrahedron with Irene and Jean-Claude in 2003.

PhD in Organic Chemistry (1990) Director of Chemistry

Following her doctorate at Darmstadt and a Post-Doc in Paris, Irene joined Bioxytech in 1992, a French biotech company focused on Free Radical Biology. Irene led R&D projects for 7 years within Bioxytech/Oxis SA and acted as Director of Chemistry of Oxis SA. After leading R&D-projects for active photoprotection at L’Oréal, Irene co-created Expertise and Consulting in 2001, a CRO in Medicinal Chemistry. Irene co-founded Tetrahedron with Jean-Claude and Marc in 2003.

Ph.D. in Medicinal Chemistry (1983) – President

After working for Roussel-Uclaf as research chemist, Jean-Claude co-founded Bioxytech in 1989, a French biotech company focused on Free Radical Biology. Jean-Claude led R&D projects within Bioxytech/Oxis SA and acted as Chief Scientific Officer and Managing Director of Oxis SA. Jean-Claude created Analytics Biophysics International in 1998, a CRO in Bioanalytical Chemistry, and co-created Expertise and Consulting in 2001, a CRO in Medicinal Chemistry. Jean-Claude co-founded Tetrahedron with Irene and Marc in 2003.